Clinical Trials in Atlanta

Showing 10561-10580 of 19,805 trials

Phase 2/3 Study of IGSC, 20% in PIDD

NCT01218438

The purpose of this study is to develop a 20% subcutaneous (SC) immunoglobulin preparation for the treatment of patients with primary immunodeficiency diseases (PIDD).

Primary Immunodeficiency Diseases (PID)

Baxalta now part of Shire86 participantsStarted Jan 2013

Irvine, California, United States • Centennial, Colorado, United States • North Palm Beach, Florida, United States +15 more locations

COMPLETEDPhase 2< 1 mile

A Study to Evaluate the Safety and Pharmacology of Subcutaneous Administration of CINRYZE With Recombinant Human Hyaluronidase

NCT01426763

The objectives of the study are to: 1. Evaluate the safety and tolerability of subcutaneously administered CINRYZE with recombinant human hyaluronidase (rHuPH20) in subjects with hereditary angioedema (HAE) who previously participated in CINRYZE Study 0624-200 (NCT01095497) 2. Characterize the pharmacokinetics and pharmacodynamics of subcutaneously administered CINRYZE with rHuPH20 3. Assess the immunogenicity of CINRYZE following subcutaneous (SC) administration of CINRYZE with rHuPH20

Hereditary Angioedema

Shire12 participantsStarted Sep 2011

Scottsdale, Arizona, United States • Walnut Creek, California, United States • Atlanta, Georgia, United States +1 more locations

Phase 2/3 Study of IGSC, 20% in PIDD

A Study to Evaluate the Safety and Pharmacology of Subcutaneous Administration of CINRYZE With Recombinant Human Hyaluronidase

Find Trials by Condition in Atlanta

Treatment of Chronic Deep Vein Thrombosis (DVT) and Post-Thrombotic Syndrome (PTS) With the EkoSonic® Endovascular System

QPI-1002 Phase 3 for Prevention of Major Adverse Kidney Events (MAKE) in Subjects at High Risk for AKI Following Cardiac Surgery

A Long Term Study of ALKS 5461 in the Treatment of Refractory Major Depressive Disorder (MDD)

NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study

Safety, Tolerability, and Efficacy of Monotherapy and Combination Regimens in Participants With Nonalcoholic Steatohepatitis (NASH)

Study of Cryoablation for Metastatic Lung Tumors

Dose Response of 28 Days of Dosing of GSK962040 in Type I and II Diabetic Male and Female Subjects With Gastroparesis

LVRC IDE Crossover Study (Crossover From IDE Trial CLN0009)

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ABBV-3373 in Participants With Moderate to Severe Rheumatoid Arthritis (RA)

Folate Receptor Alpha Peptide Vaccine With GM-CSF in Patients With Triple Negative Breast Cancer

Efficacy and Safety of LBH589B in Adult Patients With Refractory Chronic Myeloid Leukemia in Accelerated or Blast Phase

Evaluation of Renal Function in Subjects Who Had Undergone Cardiac Surgery

Study to Prevent Acute Kidney Injury After Cardiac Surgery Involving Cardiopulmonary Bypass

A Phase 2, to Evaluating the Safety and Efficacy of Pridopidine Vs Placebo for Symptomatic Treatment in Patients With Huntington's Disease

Efficacy and Safety Study of Certolizumab Pegol (CZP) Versus Active Comparator and Placebo in Subjects With Plaque Psoriasis (PSO)

Cebranopadol Efficacy and Safety in Diabetic Patients Suffering From Chronic Pain Caused by Damage to the Nerves

Safety and Efficacy of Cryoablation for the Palliation of Painful Bone Metastases

Safety Study for Beta Thalassemia Subjects on PTG-300